AMETEK, Inc. AME SPXR3K
Company Overview
AMETEK, Inc. manufactures and sells electronic instruments (EIG) and electromechanical (EMG) devices in the United States and internationally. It operates through EIG and EMG segments. The company offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and metering devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and gas turbines sensors; dashboard instruments for heavy trucks and other vehicles; instrumentation and controls for food and beverage industries; and aircraft and engine sensors, embedded computing, monitoring, power supplies, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry. It also provides engineered medical components and devices, automation solutions, thermal management systems, specialty metals, and electrical interconnects; single-use and consumable surgical instruments, implantable components, and drug delivery systems; engineered electrical connectors and electronics packaging; precision motion control products for data storage, medical devices, business equipment, automation, and other application; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for thermal management, military and commercial aircraft, and military ground vehicles; and motors used in commercial appliances, food and beverage machines, hydraulic pumps, and industrial blowers, as well as operates a network of aviation maintenance, repair, and overhaul facilities. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.
Why Investors Should Care
Net profit has compounded at 11.6% per year over the last five years.
Maintains a net profit margin of 20.0%.
Carries low leverage with a debt-to-equity ratio of 0.21.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $7.40B (+6.6% YoY); net profit $1.48B.
- Trailing 12 Months Year-on-year growth — revenue +15.0%, earnings +14.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 7.6%, profit CAGR 11.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 7.58% |
| 1 Year: | 15.00% |
Compounded Profit Growth
| 5 Years: | 11.63% |
| 1 Year: | 14.20% |
Stock Price Performance
| 1 Year: | +27.98% |
| 6 Months: | +7.42% |
| 3 Months: | +5.09% |
| 1 Month: | -5.43% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)45.07 · Neutral
P/E of 34.75 is above the sector median of 27.38 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 20.0%.
- Profit CAGR of 11.6% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AME AMETEK, Inc. SPXR3K | 237.72 | 34.75 | $54.49B | 0.54% | 14.44% | 14.56% | 7.58% | 11.63% |
| 2 | SPCX Space Exploration Technologies Corp. R3KAIDEFENCE | 147.95 | -134.50 | $1.12T | 0.00% | -3.22% | -11.95% | 34.08% | -3.34% |
| 3 | CAT Caterpillar Inc. SPXR3K | 813.94 | 35.05 | $374.15B | 0.76% | 17.98% | 56.97% | 2.29% | 5.24% |
| 4 | GE GE Aerospace SPXR3KDEFENCE | 337.12 | 39.85 | $349.78B | 0.50% | 9.52% | 48.23% | -7.42% | -5.36% |
| 5 | RTX RTX Corporation SPXR3KDEFENCE | 200.79 | 35.41 | $270.62B | 1.31% | 8.28% | 12.27% | 2.61% | 2.62% |
| 6 | GEV GE Vernova Inc. SPXR3KAI | 941.95 | 26.98 | $250.87B | 0.20% | 6.30% | 82.58% | 8.68% | - |
| 7 | DE Deere & Company SPXR3K | 693.53 | 39.29 | $187.33B | 1.05% | 12.53% | 18.35% | 3.43% | 5.10% |
| 8 | UNP Union Pacific Corporation SPXR3K | 291.88 | 23.83 | $173.40B | 1.92% | 15.22% | 39.70% | 2.30% | 7.77% |
| 9 | BA The Boeing Company SPXR3KDEFENCE | 212.25 | 76.08 | $167.63B | 0.00% | -9.01% | - | 1.67% | -3.28% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.20B | 1.01B | 1.13B | 1.22B | 1.39B | 1.44B | 1.46B | 1.51B | 1.55B | 1.60B | 1.65B | 1.62B | 1.74B | 1.73B | 1.71B | 1.73B | 1.78B | 1.89B | 2.00B | 1.93B | 2.04B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.11B | 1.14B | 1.21B | 1.28B | 1.21B | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 625.00M | 635.89M | 686.14M | 720.41M | 717.56M | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 170.17M | 174.26M | 197.76M | 214.93M | 202.62M | - |
| Operating Income | 240.32M | 237.62M | 208.83M | 208.52M | 219.04M | 201.12M | 173.22M | 217.45M | 229.55M | 230.04M | 226.59M | 258.17M | 270.09M | 265.27M | 282.02M | 283.26M | 295.41M | 301.06M | 297.65M | 232.04M | 226.99M | 270.74M | 293.35M | 316.61M | 337.56M | 353.24M | 364.84M | 384.52M | 405.54M | 418.79M | 438.13M | 417.22M | 447.51M | 445.85M | 454.83M | 461.63M | 488.38M | 505.48M | 514.94M | 528.19M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 559.58M | 566.73M | 573.56M | 602.53M | 619.38M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 18.99M | 16.86M | 22.51M | 22.89M | 20.91M | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 434.22M | 442.17M | 447.96M | 473.98M | 492.98M | - |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 82.46M | 83.80M | 76.55M | 75.38M | 93.62M | - |
| Net Income | 155.51M | 156.40M | 136.84M | 134.17M | 138.19M | 130.69M | 109.11M | 138.93M | 150.48M | 153.53M | 238.53M | 181.34M | 193.86M | 191.21M | 211.52M | 204.27M | 215.50M | 220.75M | 220.78M | 280.62M | 166.22M | 204.58M | 219.23M | 231.68M | 257.46M | 272.45M | 282.37M | 297.64M | 305.71M | 324.24M | 340.37M | 310.94M | 337.68M | 340.24M | 351.76M | 358.37M | 371.42M | 398.60M | 399.36M | 406.90M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.52 | 1.55 | 1.60 | 1.73 | 1.74 | - |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.14B | 2.53B | 2.10B | 2.47B | 2.99B | 3.33B | 3.59B | 4.02B | 3.97B | 3.84B | 4.30B | 4.85B | 5.16B | 4.54B | - | 6.15B | 6.60B | 6.94B | 7.40B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.01B | 4.21B | 4.46B | 4.73B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.15B | 2.38B | 2.48B | 2.67B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 644.58M | 677.01M | 696.90M | 757.12M |
| Operating Income | 386.57M | 432.65M | 366.05M | 482.16M | 635.94M | 745.87M | 815.08M | 898.59M | 907.72M | 790.98M | 903.62M | 1.08B | 1.18B | 1.03B | - | 1.50B | 1.71B | 1.78B | 1.91B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.83B | 2.03B | 2.16B | 2.30B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 83.19M | 81.80M | 112.96M | 81.25M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.43B | 1.61B | 1.66B | 1.80B |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 269.15M | 293.22M | 285.42M | 318.20M |
| Net Income | 228.02M | 246.95M | 205.77M | 283.93M | 384.46M | 459.13M | 517.00M | 584.46M | 590.86M | 512.16M | 681.47M | 777.93M | 861.30M | 872.44M | - | 1.16B | 1.31B | 1.38B | 1.48B |
| Diluted EPS | 2.12 | 1.53 | 1.27 | 1.18 | 1.58 | 1.88 | 2.10 | 2.37 | 2.45 | 2.19 | 2.94 | 3.34 | 3.75 | 3.77 | - | 5.01 | 5.67 | 5.93 | 6.40 |
| R&D Expense | - | 57.50M | 50.50M | 56.80M | 78.00M | 84.90M | 93.90M | 119.30M | 116.30M | 112.00M | 130.40M | 141.00M | 161.90M | 158.90M | 194.20M | 198.80M | 220.80M | 236.60M | 236.10M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 3.06B | 3.25B | 3.82B | 4.32B | 5.19B | 5.88B | 6.42B | 6.66B | 7.10B | 7.80B | 8.66B | 9.84B | 10.36B | - | 12.43B | 15.02B | 14.63B | 16.07B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.53B | 2.82B | 2.60B | 3.02B |
| Cash & Equivalents | 49.09M | 170.14M | 86.98M | 246.36M | 163.21M | 170.39M | 157.98M | 295.20M | 377.62M | 381.00M | 717.26M | 646.30M | 353.98M | 393.03M | 1.21B | - | 345.39M | 409.80M | 374.00M | 457.95M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.04B | 1.13B | 1.02B | 1.11B |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 919.34M | 1.01B | 948.83M | 1.12B |
| Total Liabilities | - | - | 1.77B | 1.68B | 2.04B | 2.27B | 2.65B | 2.74B | 3.18B | 3.41B | 3.84B | 3.77B | 4.42B | 4.73B | 4.41B | - | 4.95B | 6.29B | 4.98B | 5.44B |
| Current Liabilities | - | - | 447.51M | 424.28M | 550.86M | 628.88M | 879.97M | 874.54M | 936.14M | 1.02B | 924.44M | 1.14B | 1.26B | 1.43B | 1.08B | - | 1.56B | 2.88B | 2.10B | 2.84B |
| Long Term Debt | - | - | 1.09B | 955.88M | 1.07B | 1.12B | 1.13B | 1.14B | 1.43B | 1.55B | 2.06B | 1.87B | 2.27B | 2.27B | 2.28B | - | 2.16B | 1.90B | 1.43B | 1.07B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.43B | 3.37B | 2.13B | 2.34B |
| Total Equity | - | 1.24B | 1.29B | 1.57B | 1.78B | 2.05B | 2.54B | 3.14B | 3.24B | 3.25B | 3.26B | 4.03B | 4.24B | 5.12B | 5.95B | - | 7.48B | 8.73B | 9.66B | 10.63B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 268.59M | 269.28M | 270.06M | 270.47M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 278.52M | 247.26M | 364.67M | 423.01M | 508.56M | 612.46M | 660.66M | - | - | 756.84M | 833.26M | 925.52M | 1.11B | 1.28B | - | 1.15B | 1.74B | 1.83B | 1.80B |
| Investing Cash Flow | -334.66M | -496.62M | -106.34M | -566.82M | -526.45M | -803.73M | -460.33M | - | - | -452.37M | -625.82M | -1.21B | -1.15B | 61.63M | - | -552.76M | -2.38B | -244.81M | -1.06B |
| Financing Cash Flow | 174.10M | 173.46M | -102.52M | 62.63M | 31.86M | 174.54M | -70.28M | - | - | 57.05M | -329.17M | 13.04M | 72.91M | -539.44M | - | -575.70M | 697.28M | -1.60B | -686.32M |
| Capital Expenditure | -37.62M | -44.22M | -33.06M | -39.18M | -50.82M | -57.43M | -63.31M | -71.33M | -69.08M | -63.28M | -75.07M | -82.08M | -102.35M | -74.20M | - | -139.00M | -136.25M | -127.08M | -130.25M |
| Free Cash Flow | 240.90M | 203.05M | 331.61M | 383.83M | 457.75M | 555.04M | 597.35M | - | - | 693.55M | 758.18M | 843.44M | 1.01B | 1.21B | - | 1.01B | 1.60B | 1.70B | 1.67B |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20.91M | 56.15M | -18.41M | 52.67M |
| Share Buybacks | 5.44M | 57.44M | 0 | 78.61M | 59.34M | 4.64M | 8.47M | 245.28M | 435.40M | 336.14M | 6.87M | 367.68M | 11.92M | 4.68M | 14.71M | 332.82M | 7.77M | 212.03M | 434.05M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 34.9% | 36.1% | 35.7% | 36.0% |
| Operating Margin % | 18.1% | 17.1% | 17.4% | 19.5% | 21.3% | 22.4% | 22.7% | 22.3% | 22.8% | 20.6% | 21.0% | 22.2% | 22.8% | 22.6% | - | 24.4% | 25.9% | 25.6% | 25.8% |
| Net Margin % | 10.7% | 9.8% | 9.8% | 11.5% | 12.9% | 13.8% | 14.4% | 14.5% | 14.9% | 13.3% | 15.8% | 16.1% | 16.7% | 19.2% | - | 18.9% | 19.9% | 19.8% | 20.0% |
| ROE % | 18.4% | 19.2% | 13.1% | 16.0% | 18.7% | 18.1% | 16.5% | 18.0% | 18.2% | 15.7% | 16.9% | 18.3% | 16.8% | 14.7% | - | 15.5% | 15.0% | 14.3% | 13.9% |
| ROCE % | - | 16.6% | 13.0% | 14.8% | 17.2% | 17.3% | 16.3% | 16.4% | 16.1% | 12.8% | 13.6% | 14.5% | 14.0% | 11.1% | - | 13.8% | 14.1% | 14.2% | 14.4% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 8.52% | 19.53M | $4.61B |
| 2 | Vanguard Capital Management LLC | 6.54% | 14.98M | $3.54B |
| 3 | State Street Corporation | 4.51% | 10.34M | $2.44B |
| 4 | Vanguard Portfolio Management LLC | 4.34% | 9.95M | $2.35B |
| 5 | Price (T.Rowe) Associates Inc | 2.94% | 6.74M | $1.59B |
| 6 | Geode Capital Management, LLC | 2.68% | 6.14M | $1.45B |
| 7 | JPMORGAN CHASE & CO | 1.91% | 4.37M | $1.03B |
| 8 | NORGES BANK | 1.88% | 4.30M | $1.02B |
| 9 | FMR, LLC | 1.87% | 4.28M | $1.01B |
| 10 | Morgan Stanley | 1.63% | 3.75M | $884.95M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AME
AMETEK (AME) Stock Looks Fully Priced On Its Indicor Deal
AMETEK stock has delivered a strong 83.6% total return over the past five years, yet current checks suggest the shares are not a clear bargain. The Discounted Cash Flow (DCF) estimate points to a price that is broadly in line with intrinsic…
AMETEK (AME) Earnings Beat And Higher Outlook Put Valuation Back In Focus
AMETEK (AME) drew investor attention after second quarter 2026 results topped analyst expectations, with revenue rising 15% to US$2.04b and both earnings and sales surpassing consensus estimates. Despite the Q2 beat, AMETEK’s recent share p…
Why Is Ametek (AME) Down 8.5% Since Last Earnings Report?
Ametek (AME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Firing on All Cylinders: AMETEK (NYSE:AME) Q2 Earnings Lead the Way
Let’s dig into the relative performance of AMETEK (NYSE:AME) and its peers as we unravel the now-completed Q2 internet of things earnings season.
AMETEK Completes Acquisition of Indicor Instrumentation
AMETEK, Inc. (NYSE: AME) today announced that it has completed its previously announced acquisition of a portfolio of instrumentation businesses from Indicor, LLC, ("Indicor Instrumentation") in an all‑cash transaction valued at $5.0 billio…
Ametek (AME) Upgraded to Buy: Here's Why
Ametek (AME) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AME — Frequently Asked Questions
What is the current share price of AMETEK, Inc. (AME)?
As of 2026-09-07 16:24 PDT, AMETEK, Inc. (AME) trades at $237.72 on NYSE. Its 52-week range is $178.45 to $258.52.
What is the market capitalisation of AME?
AMETEK, Inc. (AME) has a market capitalisation of $54.49B on NYSE.
What is the P/E ratio of AME?
AME trades at a trailing price-to-earnings (P/E) ratio of 34.75. The industry average P/E is 27.38. Its price-to-book (P/B) ratio is 5.32.
Does AME pay a dividend?
AMETEK, Inc. (AME) currently offers a dividend yield of 0.54%.
What is the return on equity (ROE) of AME?
AME has a return on equity (ROE) of 14.56%. Its return on capital employed (ROCE) is 14.44%.
Is AME a good stock to buy?
This page provides a data-driven analysis of AMETEK, Inc. (AME), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.